Clinicians

High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts

Servier’s $2.65B Muscular Dystrophy Deal Turns Rare Neurology Into a Commercial Priority

Alzheimer’s Blood Testing Moves the Disease Clock Earlier

Lenacapavir Turns HIV Prevention Into an Access Stress Test

WHO’s New AMR Plan Makes Stewardship and Access a Single Test

Physical activity continues to strengthen its case as a cross-disease prevention strategy

Can cortisol become the next target in type 2 diabetes?

The Air We Breathe May Be Shaping the Future Burden of Blindness

Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
